Mortality News and Research

RSS

Smoking continues to be a leading cause of cancer-related death

A new study led by researchers at the American Cancer Society (ACS) reports nearly 123,000 cancer deaths, or close to 30 percent of all cancer deaths, were from cigarette smoking in the United States in 2019, leading to more than two million Person-Years of Lost Life (PYLL) and nearly $21 billion in annual lost earnings. These losses were disproportionately higher in states with weaker tobacco control policies in the South and Midwest. The results were published today in the International Journal of Cancer.

11 Aug 2022

International medical experts aim to use biomarker-based approaches to advance precision medicine

The diagnostics company SphingoTec GmbH (SphingoTec), announces that, during the 4th Scientific Symposium held near Potsdam, Germany, international medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.

11 Aug 2022

How ultraprocessed foods affect gut microbiome and health

Researchers describe the association between the consumption of ultraprocessed foods and chronic medical conditions.

10 Aug 2022

What is the risk of COVID-19 community transmission at US universities?

In a new study, researchers assessed the risk of community transmission of COVID-19 in US universities.

10 Aug 2022

Next-generation monoclonal antibody prevents malaria

Researchers investigate the pharmacokinetics and safety of L9LS, a monoclonal antibody to prevent malaria.

9 Aug 2022

Research paves the way for therapies to treat or delay preterm labor

Researchers have identified a cause of preterm labor, an enigma that has long challenged researchers. New research published in The Journal of Physiology suggests a protein, called Piezo1, is responsible for regulating the behavior of the uterus.

9 Aug 2022

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.

9 Aug 2022

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

Researchers estimated the vaccine effectiveness (VE) of the primary and booster doses of COVID-19 vaccines against reinfection by Omicron BA.5 and BA.2 lineages and severe post-infection outcomes.

9 Aug 2022

Research projects the future mortality burden due to hot nights

Excessively hot nights caused by climate change are predicted to increase the mortality rate around the world by up to 60% by the end of the century, according to a new international study that features research from the UNC Gillings School of Global Public Health.

9 Aug 2022

Researchers unravel a novel molecular target of eicosapentaenoic acid

Eicosapentaenoic acid (EPA) is an essential nutrient belonging to the omega-3 group of polyunsaturated fatty acids (PUFAs). As the human body cannot synthesize PUFAs, dietary supplements containing EPA are required for normal physiological functions. Found abundantly in natural sources like fish, hemp oil, and linseed oil, EPA is known to exhibit anti-inflammatory, neuroprotective, and cardiovascular protective activities.

9 Aug 2022

Study compares the nodule management protocols used in NELSON and National Lung Cancer Screening Trial

The protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol used in the National Lung Cancer Screening Trial, particularly for early-stage cancers, according to research reported today at the IASLC World Conference on Lung Cancer 2022 in Vienna.

8 Aug 2022

Sub lobar surgery found to be non-inferior to lobectomy for patients with small-sized peripheral NSCLC

A large international study of patients with non-small cell lung cancer tumors that are two centimeters or less found that sub lobar surgery was non-inferior to lobectomy, according to results presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna.

8 Aug 2022

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Researchers assessed the impact of dendrimer nanotherapy in treating severe COVID-19.

8 Aug 2022

Sauna together with exercise is a viable preemptive combination for lowering cardiovascular disease risk

Eight weeks of regular sauna bathing and exercise was found to be superior to regular exercise alone for the improvement of three major cardiovascular disease (CVD) risk factors in the general population.

8 Aug 2022

What were the health effects of long COVID during the SARS-CoV-2 Omicron wave?

A new study examined the health influences of long coronavirus disease during the 2021 to 2022 SARS-CoV-2 Omicron surge in Australia.

8 Aug 2022

Study finds COVID associated with abnormal placental pathologies in nearly 50% of cohort

Researchers describe the impact of placental morphological changes in COVID-19 on pregnancy outcomes.

7 Aug 2022

Skin cancer is a risk no matter the skin tone. But it may be overlooked in people with dark skin.

Brykyta Shelton found herself standing in a checkout line of a big-box retailer, uncomfortably aware as a woman ahead of her stared at her sandaled feet.

5 Aug 2022

Gut microbiota-derived metabolites offer protection against SARS-CoV-2

A new study investigated how the gut microbiome confers immunity to mammalian hosts against SARS-CoV-2 intranasal infection by generating short-chain fatty acids.

5 Aug 2022

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Primary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the United States each year. The high mortality rates can be attributed in part to the fact that a significant portion of the patients are detected at a late stage, when potentially curative treatments are no longer an option. Unfortunately, today's screening methods are not able to routinely provide accurate, early detection.

5 Aug 2022

How does the flu vaccine affect the risk of contracting COVID-19?

A new study describes the association between the risk of contracting COVID-19 and the seasonal flu vaccine.

4 Aug 2022

Mortality News and Research

Smoking continues to be a leading cause of cancer-related death

International medical experts aim to use biomarker-based approaches to advance precision medicine

How ultraprocessed foods affect gut microbiome and health

What is the risk of COVID-19 community transmission at US universities?

Next-generation monoclonal antibody prevents malaria

Research paves the way for therapies to treat or delay preterm labor

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

Research projects the future mortality burden due to hot nights

Researchers unravel a novel molecular target of eicosapentaenoic acid

Study compares the nodule management protocols used in NELSON and National Lung Cancer Screening Trial

Sub lobar surgery found to be non-inferior to lobectomy for patients with small-sized peripheral NSCLC

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Sauna together with exercise is a viable preemptive combination for lowering cardiovascular disease risk

What were the health effects of long COVID during the SARS-CoV-2 Omicron wave?

Study finds COVID associated with abnormal placental pathologies in nearly 50% of cohort

Skin cancer is a risk no matter the skin tone. But it may be overlooked in people with dark skin.

Gut microbiota-derived metabolites offer protection against SARS-CoV-2

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

How does the flu vaccine affect the risk of contracting COVID-19?

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News